Intuitive Surgical (ISRG) 10-K Summaries & Annual Filing History
Review Intuitive Surgical, Inc. (ISRG) 10-K filings from 2023 through the latest annual report, including business, financial performance, risks, and liquidity.
Key takeaway
Year ended Dec 31, 2025 · FY2025 10-K
Intuitive Surgical filed its annual report for the most recent fiscal year. The filing provides financial metrics and liquidity information but does not include a detailed business description in the supplied sections.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$10.1B
Revenue reported for the fiscal year.
Operating income
$2.9B
Income from operations reported for the year.
Net income
$2.9B
Net income reported for the year.
Operating cash flow
$3B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $6.2B | +9.0% |
| Dec 31, 2023 | $7.1B | +14.5% |
| Dec 31, 2024 | $8.4B | +17.2% |
| Dec 31, 2025 | $10.1B | +20.5% |
Business overview
The supplied filing context does not contain a description of the company's business operations. The only reference to the company's activities is in the liquidity section, which mentions product development and procedure adoption.
Financial performance
Revenue increased compared to the prior year. Operating income and net income were reported at comparable levels. Operating cash flow remained positive.
Material risks
The filing cautions that macroeconomic and geopolitical headwinds could reduce cash flow from operations. It also notes that the company's cash requirements depend on product acceptance and other factors.
Liquidity and capital
Cash and investments increased, primarily from operating activities and stock-related proceeds, partially offset by share repurchases and capital expenditures. The company expects to fund future growth through operating cash flow.
What to watch
Monitor the company's progress in expanding procedure adoption and product acceptance, as these are key drivers of revenue and cash flow.